Improving asthma symptom perception in children using a feedback tool
Official title: The Rainbow Study - a Randomized Controlled Trial to Evaluate the Effect of Personalized Feedback on Symptom Perception in Asthmatic Children
Run by Medisch Spectrum Twente · NCT06702735 · Data updated 2026-11-12
This study is testing a new tool to help kids aged 7 to 15 understand their asthma symptoms better so they can manage their condition more effectively.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 7 Years to 15 Years |
| Sex | All |
| Enrollment | 39 (estimated) |
| Sponsor | Medisch Spectrum Twente Academic / other |
| Drugs / interventions | prednisone |
| Locations | 1 site (Enschede, Overijssel) |
| Status | Recruiting |
| Started | October 16, 2023 |
| Main results expected | February 1, 2024 |
| Study ends | May 1, 2025 |
| Registry record updated | November 25, 2024 |
| Trial ID | NCT06702735 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are children aged 7 to 15 diagnosed with asthma who may have poor symptom perception.
✕Probably not a fit
Patients with severe comorbidities or those unable to understand or complete the required assessments may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to enhance the understanding of asthma symptoms in children aged 7 to 15 by utilizing the Rainbow tool, which visualizes the relationship between lung function and symptom perception. The study involves regular lung function measurements and personalized feedback to help children better recognize and report their symptoms. By identifying children with poor symptom perception, the study seeks to improve their ability to manage asthma effectively. The approach is designed to empower young patients through better awareness of their condition.
Why it matters
Potential benefit: If successful, this study could lead to improved asthma management and quality of life for children by enhancing their ability to perceive and respond to their symptoms.
How similar studies have gone: While the specific use of the Rainbow tool is novel, similar approaches focusing on symptom perception in asthma have shown promise in other studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Selection phase: * Pediatrician diagnosed asthma * Health care professional thinks perception might be poor * Age 7 until 15 years old * Adequate understanding of Dutch language Intervention phase: * Adequate number of lung function measurements + VAS scores during selection phase, defined as: * At least 4 measurements after exercise or when experiencing symptoms and * At least 2 standard measurements * Poor perception during selection phase, defined as: * At least 1 measurement in red zone on Perception Rainbow and/or * At least 2 measurements in orange zone on Perception Rainbow and/or * Average of all measurements after exercise or when experiencing symptoms in yellow zone (or orange/red)and/or * Average of all measurements in yellow zone (or orange/red) Exclusion Criteria: * Severe comorbidity (for example psychomotor retardation or severe cardiopulmonary conditions) * Not able to fill in VAS score (for example due to blindness) * Not able to perform technically correct spirometry manoeuvres * Medication change in past 2 weeks * Exacerbation which required oral prednisone in the past 6 weeks * Exacerbation at the moment of inclusion * No device (computer, tablet or smartphone) with internet connection available at home
Where it's running
-
Medisch Spectrum Twente
Enschede, Overijssel, Netherlands Recruiting
Study contacts
- Principal investigator: Vera Hengeveld, MD — Medisch Spectrum Twente
- Study coordinator: Vera Hengeveld, MD
- Email: vera.hengeveld@mst.nl
- Phone: +31534872310
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
N-WATCH: Can a simple breath device help monitor asthma in kids
This study tests the N-Tidal C device to see if it helps monitor asthma in children aged 5 to under 16 who have wheeze or asthma and are not critically ill.
-
Smart Inhaler Use at Home for Adolescents with IDD and Asthma
This study tests whether daily use of active smart inhalers at home helps adolescents with intellectual disabilities manage asthma better.
-
ASMact: Managing bronchial asthma attacks in children
This study tries a GINA 2025-based staff education and care-standardization approach to see if emergency treatment for children aged 6–17 with acute asthma attacks improves outcomes.
-
Biomarkers and Respiratory Omics in Children: Predicting Disease Course
This study tests whether biomarkers from the lungs and blood can predict how asthma and protracted bacterial bronchitis in children will progress and respond to current therapies.
-
Using technology and school–clinic coordination to improve asthma care for children.
This project will try a tech-enabled program plus school care coordination to help children ages 4–12 with persistent or uncontrolled asthma follow guideline-based treatment and have fewer symptoms and school problems.
-
Boosting use of SMART inhaler therapy for children with moderate-to-severe asthma
This project will test whether adding community health workers and nurse care managers to electronic health record decision support and education helps children ages 5–18 with uncontrolled asthma use single maintenance and reliever therapy (SMART).
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.